Skip to main content

Biostar 2 CVE-2023-33363

HIGH
Improper Authentication (CWE-287)
2023-08-03 cve@mitre.org
7.5
CVSS 3.1 · NVD
Share

Severity by source

NVD PRIMARY
7.5 HIGH
AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N
Attack Vector
Network
Attack Complexity
Low
Privileges Required
None
User Interaction
None
Scope
Unchanged
Confidentiality
None
Integrity
High
Availability
None

Lifecycle Timeline

1
CVE Published
Aug 03, 2023 - 16:15 nvd
HIGH 7.5

DescriptionNVD

An authentication bypass vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated users to access some functionality on BioStar 2 servers.

AnalysisAI

An authentication bypass vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated users to access some functionality on BioStar 2 servers. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified as Improper Authentication (CWE-287), which allows attackers to bypass authentication mechanisms to gain unauthorized access. An authentication bypass vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated users to access some functionality on BioStar 2 servers. Affected products include: Supremainc Biostar 2. Version information: before 2.9.1.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Implement multi-factor authentication, enforce strong password policies, use proven authentication frameworks.

Share

CVE-2023-33363 vulnerability details – vuln.today

This site uses cookies essential for authentication and security. No tracking or analytics cookies are used. Privacy Policy